Drug intelligence / Profile preview

Nerve Health Formula

Development stage: Preclinical
Lead developer: Ethos Research & Development
Administration: Oral

Overview

Nerve Health Formula is a dietary supplement composed of Hydroxocobalamin (Vitamin B12, 1000mcg), Pyridoxal-5-Phosphate (Vitamin B6, 50mg), L-Methylfolate (400mcg), and Trimethyl Glycine (Betaine, 750mg). It is specifically designed to support nerve health and is being evaluated in a pilot study by Ethos Research & Development to assess its impact on quality-of-life measures and urinary biomarker scores in subjects with chronic pain. The formula aims to address deficiencies related to nerve health through targeted nutritional supplementation.

Targets

BHMT (Betaine-homocysteine S-methyltransferase)

Beyond the preview

Go deeper on Nerve Health Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nerve Health Formula.

Explore the full profile